Polyomavirus BK-specific CD8 T cell responses in patients after allogeneic stem cell transplant

Leukemia and Lymphoma

Volumn 51, Issue 6, 2010, Pages 1055-1062

  Schneidawind, Dominik ^a   Schmitt, Anita ^a   Wiesneth, Markus ^b   Mertens, Thomas ^b   Bunjes, Donald ^b   Freund, Mathias ^a   Schmitt, Michael ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Allogeneic stem cell transplant; BK virus; CD8T cells; Polyomavirus

Indexed keywords

HLA A2 ANTIGEN; PROTEIN VP1; EPITOPE; PEPTIDE; VIRUS PROTEIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BK VIRUS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; AGED; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; CD4+ T LYMPHOCYTE; CHEMISTRY; COMPLICATION; CYSTITIS; FLOW CYTOMETRY; HEMORRHAGE; IMMUNOLOGY; MIDDLE AGED; POLYOMAVIRUS INFECTION; PROCEDURES; STEM CELL TRANSPLANTATION; SYNTHESIS; T LYMPHOCYTE; YOUNG ADULT;

ADULT; AGED; AMINO ACID SEQUENCE; BK VIRUS; CD4-POSITIVE T-LYMPHOCYTES; CYSTITIS; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; POLYOMAVIRUS INFECTIONS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; VIRAL PROTEINS; YOUNG ADULT;

EID: 77953521568     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428191003746323     Document Type: Article

References (24)

1. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009;199:837-846.
2. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009;5:e1000363.
3. Leung AYH, Yuen K, Kwong Y. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005;36:929-937.
4. Giraud G, Bogdanovic G, Priftakis P, et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006;91:401-404.
5. Tsuboi K, Kishi K, Ohmachi K, et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:903-907.
6. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006;81:535-537.
7. Garderet L, Bittencourt H, Sebe P, et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 2000;70:1807-1811.
8. Laszlo D, Bosi A, Guidi S, et al. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica 1995; 80:421-425.
9. Purves JT, Graham ML, Ramakumar S. Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology 2005;66:641-643.
10. Lache M, Jacob F, Schmitt A, et al. Levofloxacin prophylaxis decreases the incidence of BK polyomavirus-induced haemorrhagic cystitis in patients after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 45(Suppl. 2):227.
11. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirusassociated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 2006;8:86-94.
12. Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007;7:1131-1139.
13. Chen Y, Trofe J, Gordon J, Autissier P, Woodle ES, Koralnik IJ. BKV and JCV large T antigen-specific CD8+T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008;42:198-202.
14. Chen Y, Trofe J, Gordon J, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006;80:3495-3505.
15. Krymskaya L, Sharma MC, Martinez J, et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005;79:11170-11178.
16. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994; 152:163-175.
17. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213-219.
18. Wong ASY, Cheng VCC, Yuen K-Y, Kwong Y-L, Leung AYH. High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant 2009;43:43-47.
19. Lima MA, Marzocchetti A, Autissier P, et al. Frequency and phenotype of JC virus-specific CD8+T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007;81: 3361-3368. (Pubitemid 46456645)
20. Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and consequential selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+T cells leads to enduring virus clearance in patients after allogeneic stem cell transplantation. Blood 2008;112(Suppl. 1):1181.
21. Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant 2008;41:193-198.
22. Greiner J, Li L, Ringhoffer M, et al. Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+T cells of HLA-A2-positive patients with acute myeloid leukemia. Blood 2005;106:938-945.
23. Li J, Melenhorst J, Hensel N, et al. T-cell responses to peptide fragments of the BK virus T antigen: implications for crossreactivity of immune response to JC virus. J Gen Virol 2006; 87:2951-2960.
24. Sharma MC, Zhou W, Martinez J, et al. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology 2006; 350:128-136.